While these pharma stocks have steady cash flows and revenues, there’s still plenty of growth left in the tank from new drugs in development. These dividend-paying biotech stocks could be the best way to play the sector. Their dividends make them less volatile than the lotto tickets, but there’s still plenty of upside potential as well. And with the overall market down in the dumps, many of these strong dividend-paying biotech stocks are now trading for peanuts. That means investors have plenty of opportunities to score some great deals. With that, here are five dividend-paying biotech stocks you need to scoop up today...
There’s no denying that Amgen (NASDAQ:AMGN) is king of biotech stocks. Like Amgen, Gilead Sciences (NASDAQ:GILD) built its impressive dividend on the back of several key blockbuster drugs. At first blush, the next of our dividend stocks, French drug producer Sanofi (NYSE:SNY), looks more like a traditional pharmaceutical firm. Truth be told, Allergan (NYSE:AGN) could be the biggest bargain of any stock on this list. A big-time approval can do wonders for your future. Just ask AbbVie Inc. (NASDAQ:ABBV).
Source: InvestorPlace
Related Articles:
- Building Yield: 6 Consumer Goods Dividend Stocks
- Why Dividend Growth Stocks Are Evil
- 4 Higher-Yielding Financial Services Stocks With Rising Dividends
- 5 Higher Yield Dividend Growth Stocks
- Successful Investors Take The Emotion Out
________________________________________________________________
Subscribe to:
Post Comments (Atom)
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.